30
Participants
Start Date
June 17, 2011
Primary Completion Date
April 7, 2017
Study Completion Date
April 7, 2017
Ipilimumab
10 mg/kg by vein over 90 minutes once every 4 weeks, for 4 weeks.
Leuprolide
7.5 mg intramuscular once a month for 8 months
Goserelin
3.6 mg subcutaneous once a month for 8 months
Degarelix
80 mg subcutaneous once a month for 8 months
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
M.D. Anderson Cancer Center
OTHER